I-US Food and Drug Administration muva nje yenza igxathu elibalulekile ekulweni nesifo i-Alzheimer ngokugunyaza i-donanemab, i-monoclonal antibody eyakhiwe ngu-Eli Lilly. Imakethwa ngaphansi kwegama elithi Kisunla, lokhu kwelashwa okusha kuhlose ukunciphisa ukuqhubekela phambili kwesifo i-Alzheimer's esinezimpawu zangaphambi kwesikhathi ngokusiza umzimba ukuthi ukhiphe ukwakheka koqweqwe lwe-amyloid ebuchosheni—uphawu lwe-Alzheimer's. Lokhu kugunyazwa akubonisi nje isikhathi esibalulekile ocwaningweni lwe-Alzheimer kodwa futhi kugqamisa ukubaluleka kokutholwa kusenesikhathi nokungenelela.
I-Kisunla: Isahluko Esisha Ekwelashweni kwe-Alzheimer
I-Donanemab, noma i-Kisunla, ayilona ikhambi le-Alzheimer's kodwa ibonise imiphumela ethembisayo ezivivinyweni zomtholampilo. Abahlanganyeli abathathe i-Kisunla bathola ingozi ephansi engu-35% yokuqhubeka kwesifo phakathi nezinyanga eziyi-18 uma kuqhathaniswa nalabo abaku-placebo. Lokhu kusho ukuthi iziguli zingaphila ngokuzimela futhi zihlanganyele ngokuphephile emisebenzini yansuku zonke isikhathi eside.
Nokho, kubalulekile ukuqaphela ukuthi ukwelashwa akunazo izingozi. Cishe u-2% wabahlanganyeli wabhekana nezenzakalo ezimbi ezimbi kakhulu, kuhlanganise nokungajwayelekile kwe-imaging okuhlobene ne-amyloid (ARIA), okungaholela ekopheni okuncane kobuchopho. Ngaphandle kwalezi zingozi, abeluleki be-FDA babone ukwelashwa kuphephile futhi kusebenza ngempumelelo, uma kubhekwa izinzuzo zako ezingaba khona.
Ukubaluleka Kokutholwa Kusenesikhathi
Ukutholwa kusenesikhathi kanye nokuxilongwa kubalulekile ekwelapheni okusebenzayo kwesifo i-Alzheimer's. I-Kisunla isebenza kahle kakhulu ezigabeni zokuqala zezimpawu, ikhuthaza u-Eli Lilly ukuthi asebenzisane nezinye izinhlangano ukuze kuthuthukiswe izindlela zokutholwa kusenesikhathi. Lolu hlelo luhambisana nesidingo esikhulayo sokungenelela kusenesikhathi, ikakhulukazi njengoba inani lamacala e-Alzheimer kulindeleke ukuthi lifinyelele cishe ezigidini eziyi-14 ngo-2060.
Iqhaza Lokunakekelwa Kwasekhaya Ekulawuleni I-Alzheimer's
Njengoba isifo i-Alzheimer siqhubeka, indima yabanakekeli iya ngokuya ibaluleke kakhulu. Abanakekeli basekhaya, abahlinzeka ngokunakekelwa nokusekelwa okuqhubekayo, badlala indima ebalulekile ekuqinisekiseni ukuphepha kanye nokuphila kahle kweziguli ze-Alzheimer's. Emindenini ephethe i-Alzheimer's ekhaya, imikhiqizo efana naleyo ehlinzekwa yi-LIREN Healthcare ingaba wusizo olukhulu.
I-LIREN Healthcare igxile emikhiqizweni yokunakekelwa kwezempilo ephezulu eklanyelwe ukuthuthukisa ukuphepha kwasekhaya nokusebenza kahle kokunakekelwa. Ibanga lethu lihlanganisa umbhede kanye nomfutho wesihlaloizinzwa pads, iyaxwayisaama-pagers, futhishayela izinkinobho, konke okubalulekile ekudaleni indawo ephephile nevikelekile yasekhaya yabantu abadala.
Ukuthuthukisa Ukuphepha Kwasekhaya nge-LIREN Healthcare Products
1.Amaphedi Enzwa Yokucindezela: Lawa maphedi abekwa phezu kwemibhede noma ezihlalweni ukuze kuqashwe ukunyakaza nokubona lapho umuntu osekhulile esukuma, ngaleyo ndlela avimbele ukuwa.
2.Amakhasi Okwazisa: Le mishini yazisa abanakekeli ngokushesha lapho umuntu osekhulile edinga usizo, ukuqinisekisa ukusabela okusheshayo nokunciphisa ingozi yezingozi.
3.Izinkinobho Zokushaya: Lokhu kuvumela abadala ukuthi bacele usizo ngomshini wokunyathelisa olula, okunikeza ukuthula kwengqondo kokubili iziguli kanye nabanakekeli bazo.
Ngokuhlanganisa imikhiqizo ye-LIREN Healthcare isethaphu yokunakekelwa kwasekhaya, imindeni ingakha indawo ephephile yabathandekayo bayo. Kulabo abacabanga ukufaka isistimu ye-alamu yokuvikela, okuhlanganisa izinzwa zokucindezela kanye nama-pager axwayisayo kungaba isengezo esibalulekile esimisweni sokubuka sokunakekelwa kwasekhaya.
Ukulondeka Nokuthula Engqondweni
Ukufaka isistimu yokuvikela ehlanganisa imikhiqizo ye-LIREN Healthcare kungathuthukisa kakhulu ukuphepha nokuvikeleka kwesiguli se-Alzheimer's ekhaya. Inqubo yethu yokufaka isistimu ye-alamu yokuvikela iqondile futhi yakhelwe ukunikeza ukuvikeleka okuphezulu ngokuphazamiseka okuncane.
Ngibheke Phambili
Ukugunyazwa kwe-Kisunla kumelela inqubekelaphambili ebalulekile ekwelashweni kwe-Alzheimer, okunikeza ithemba elisha ezigidini ezithintwe yilesi sifo esibhubhisayo. Njengoba siqhubeka nokuhlola nokuthuthukisa izindlela zokwelapha ezintsha, indima yokunakekelwa kwasekhaya kanye nemikhiqizo emisha efana naleyo evela e-LIREN Healthcare izobaluleka kakhulu ekulawuleni isifo i-Alzheimer's.
Ukuze uthole ulwazi olwengeziwe mayelana nokuthi imikhiqizo ye-LIREN Healthcare ingakusiza kanjani ukuthi wakhe indawo yasekhaya ephephile yabathandekayo bakho, vakashela iwebhusayithi yethu. Hlala unolwazi mayelana nentuthuko yakamuva ekunakekelweni kwezempilo kwabantu abadala futhi uthole izixazululo ezingcono kakhulu zokuthuthukisa ikhwalithi yempilo yabadala.
Isifinyezo
Impi yokulwa ne-Alzheimer's isekude ukuphela, kodwa ngokuphumelela okufana ne-Kisunla nokusekelwa okuqhubekayo kwemikhiqizo yokunakekelwa kwasekhaya evela ezinkampanini ezifana ne-LIREN Healthcare, kunethemba lekusasa elingcono. Njengoba samukela le ntuthuko entsha, ukuqinisekisa ukuphepha kanye nokuphila kahle kweziguli ze-Alzheimer kuseza kuqala kithi.
Vakashela iwebhusayithi ye-LIREN Healthcare namuhla ukuze ufunde kabanzi mayelana nemikhiqizo yethu nokuthi ingakusiza kanjani ukuthi wakhe indawo yasekhaya ephephile, evikeleke kakhudlwana yabathandekayo bakho. Hlala uxhumene nathi ukuze uthole izindaba zakamuva nezibuyekezo ekunakekelweni kwezempilo kwabantu abadala.
Umthombo wezindaba:https://edition.cnn.com/2024/07/02/health/lilly-azheimers-donanemab-fda/index.html
I-LIREN ifuna ngenkuthalo abasabalalisi ezosebenzisana nabo ezimakethe ezibalulekile. Abanentshisekelo bayakhuthazwa ukuthi bathinte ngecustomerservice@lirenltd.comukuze uthole imininingwane eyengeziwe.
Isikhathi sokuthumela: Jul-08-2024
